Although stimuli-responsive materials hold potential for use as drug delivery carriers for treating cancers,their clinical translation has been limited.Ideally,materials used for the purpose should be biocompatible and nontoxic,provide on-demanddrug release in response to internal or external stimuli,allow large-scale manufacturing,and per se exhibit intrinsic anticancer efficacy.